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Abstract
Group A Streptococcus (GAS) M protein is an important virulence factor and potential vaccine antigen, and constitutes the basis for strain
typing (emm-typing). Although >200 emm-types are characterized, structural data were obtained from only a limited number of emm-types.
We aim to evaluate the sequence diversity of near-full-length M proteins from worldwide sources and analyse their structure, sequence
conservation and classiﬁcation. GAS isolates recovered from throughout the world during the last two decades underwent emm-typing and
complete emm gene sequencing. Predicted amino acid sequence analyses, secondary structure predictions and vaccine epitope mapping
were performed using MUSCLE and Geneious software. A total of 1086 isolates from 31 countries were analysed, representing 175 emm-
types. emm-type is predictive of the whole protein structure, independent of geographical origin or clinical association. Findings of an emm-
type paired with multiple, highly divergent central regions were not observed. M protein sequence length, the presence or absence of
sequence repeats and predicted secondary structure were assessed in the context of the latest vaccine developments. Based on these global
data, the M6 protein model is updated to a three representative M protein (M5, M80 and M77) model, to aid in epidemiological analysis,
vaccine development and M protein-related pathogenesis studies.
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Introduction
Amongst bacterial pathogens afﬂicting humans, group A
streptococcus (GAS) is a leading cause of global morbidity
and mortality [1]. Colonization of the respiratory tract or skin
by this organism can lead to diseases that manifest in different
body sites, and require different modalities of treatment. Of
these, rheumatic heart disease (RHD) and serious strepto-
coccal invasive diseases are associated with the greatest global
mortality. Much of the GAS-associated mortality occurs in low
income regions and populations [2].
The M protein is a ﬁbrillar coiled-coil dimer that extends
from the bacterial cell wall, and is considered an archetypal
Gram-positive surface protein [3]. The M protein is a key
virulence factor and major target for GAS vaccine develop-
ment. M protein inhibits phagocytosis of GAS in the absence of
opsonising antibodies, promotes adherence to human epithe-
lial cells and helps the bacterium overcome innate immunity
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[4]. The multifunctional nature of this protein is also evident
from its interactions with numerous host proteins [4],
occurring along the entire length of the surface-exposed
portion of M protein.
Most of the M protein sequence consists of heptad repeat
motifs in which the ﬁrst and fourth amino acids are typically
hydrophobic, and are core stabilizing residues within the coiled
coil [5]. Heterogeneity in the amino acid sequence of the N-
terminal part of M protein, resulting in antigenic diversity,
forms the basis of GAS serotyping, which was used for many
decades [6,7]. Serotyping has recently been superseded by
nucleotide sequencing of the corresponding region, in a
scheme called emm-typing [6,8]. emm-type-based surveillance
studies show that the diversity of strains circulating in low
income settings far exceeds that in high income settings [9,10].
emm-typing relies on sequencing a small variable portion (10–
15%) of the complete emm gene. As a consequence, emm-
typing is not informative regarding the sequence, predicted
conformational structure or functional domains of the remain-
der of the M protein molecule, which remains largely
uncharacterized at the global level.
Another typing method, called emm pattern-typing, distin-
guishes distinct chromosomal architectures (patterns A–C, D
and E) based on the presence and arrangement of emm and
emm-like genes within the GAS genome [11]. Speciﬁc emm-
types correlate well with speciﬁc emm patterns [12]. The emm
pattern also correlates well with tissue tropism, although
several exceptions have been described [13]. Pattern A–C
strains are usually associated with throat infections, pattern D
strains are mainly recovered from superﬁcial skin infection
(impetigo), while pattern E represents a ‘generalist’ group
associated with both tissue sites. Although representing only a
small proportion of emm-types, pattern A–C strains have been
the most extensively studied [4]. Much of our understanding of
M protein structure and function is based on early work on the
M6 protein, an emm pattern A–C type [7]. The prototypical
M6 protein contains several internal repeat sequences called
‘A’, ‘B’, ‘C’ and ‘D’ repeats. Much less is known regarding the
structure of many other M proteins, particularly those
belonging to emm patterns D and E [14].
Although there is increasing interest in GAS vaccine
development by global health authorities, including the World
Health Organisation, a GAS vaccine remains unavailable. Three
M protein-based GAS vaccines are poised to enter, or are
progressing through, human clinical trials. One vaccine candi-
date incorporates amino terminal, M-type determinants from
multiple M-proteins [15], while the others consist of more
highly conserved sequences from the C repeat region (CRR)
[16–19]. Given the clinical relevance of M protein in molecular
epidemiology and GAS virulence, and its importance in vaccine
development, a comprehensive uniﬁed view of M protein is
needed. In this study we ﬁll this knowledge gap by character-
izing the complete surface-exposed portions of a large number
of M proteins from strains recovered from geographical
regions throughout the world.
Materials and Methods
Study proﬁle
Globally distributed GAS isolates recovered during two recent
decades (from 1987 to 2008) by the 25 partners of the M-
protein study groups were included in the study. Each partner
provided bacterial isolates, or genomic DNA representatives of
each emm-type in their collection. Most isolates (n = 835; 77%)
are unique representatives of a particular emm-type per country
of isolation. In some cases, two or three isolates of the same
emm-type were included if they were collected in different
regions of large countries such as the USA, Canada, Brazil and
Australia. With one exception, continents and countries were
classiﬁed according to the geoscheme created by the United
Nations Statistics Division [20]; isolates recovered from Hawaii
(USA) were artiﬁcially included in Oceania because of geo-
graphical proximity to the Paciﬁc Islands with which Hawaii
shares similar GAS epidemiology [9,10]. Clinical data were also
provided with most isolates. Eight emm-types could not be
recovered during the two last decades in our dataset (Fig. 1;
Table 1); the sequences of those particular emm-types were
obtained and described, but were not included in data analysis.
Molecular typing
PCR ampliﬁcation and sequencing of emm genes was per-
formed as previously described [14]. The alignment of the
forward and reverse emm sequences was performed using the
CodonCode Aligner version 3.7 software with default
parameters and all were manually checked. emm-type was
determined by BLASTn analysis using the CDC emm-type
database containing 223 emm-types [21]. After translation, the
predicted amino acid sequences of all M proteins were
trimmed from the ﬁrst amino acid (AA) of the predicted
mature protein to the ﬁrst AA of the D repeat near the
COOH-terminal end [14]. The size of mature M proteins
(from the ﬁrst NH2-terminal residue to the Thr of the LPXTG
sortase motif) was calculated by adding 54 or 73 residues,
respectively, to the sequence we obtained for the M proteins
of patterns E or A–C and D, as described previously [4]. The
emm pattern of at least one isolate of each of the 168 emm-
types was experimentally determined following the PCR
mapping methodology previously described [22] or deduced
from previous publications [12,14].
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Bioinformatics
Multiple alignments of trimmed amino acid sequences belong-
ing to the same emm-types were performed using the MUSCLE
algorithm with default parameters. The presence of repeat
sequences was detected by using T-reks with three different
percentage similarity (Psim) thresholds (1, 0.9 and 0.7) and
extensive manual analysis [23]. M protein annotation and
structure prediction were performed with Geneious 5.6 for
one representative of each emm-type.
Statistical analysis
The two-tailed Student’s t-test was performed using Stata 12
software.
Results
Study population
The ﬁnal dataset included 1086 GAS isolates representing 175
different emm-types recovered from 31 countries on six
continents (Fig. 1). Thus, this collection includes 78% of the
emm-types described to date [21]. Twenty per cent of the 175
emm-types belong to emm pattern A-C, while the remaining
are distributed evenly among patterns D and E (Table 1). The
number of isolates examined per emm-type ranged from 1 to
25 (mean 6.5) (Table S1). Clinical manifestations were
reported for 1019 isolates: invasive diseases (n = 365;
35.8%), pharyngitis (n = 338; 33.2%) and skin infections
(n = 233; 22.9%; includes impetigo, wound infections and
other unspeciﬁed skin infections). The remainder were
associated with oropharyngeal carriage (n = 46; 4.5%), non-
suppurative sequelae (n = 13; 1.3%) and other types of
infections (n = 24; 2.4%).
Updated structural model of M proteins
The size of the predicted mature form of M protein was highly
heterogeneous, ranging from 229 to 509 residues. Importantly,
M protein length was highly correlated with emm pattern. M
1278 representative GAS isolates received 
from 25 different epidemiological collections 
200 excluded 
   64 emm sequence not obtained 
 123 discrepant results 
     5 not coding emm sequences 
     8 SDSE associated emm sequences 
1078 contemporary GAS isolates included 
from 31 different countries*, 
representing 167 emm-types 
175 emm-types 
8 emm-types recovered 
prior to 1987 
FIG. 1. Study proﬁle. * List of countries with respective number of
isolates in brackets: Argentina (5), Australia (137), Belgium (46), Brazil
(105), Canada (69), Chile (5), Czech Republic (17), Germany (50),
Egypt (39), Ethiopia (4), Fiji (55), India (51), Israel (67), Japan (12),
Kenya (1), Malaysia (1), Mali (58), Mexico (7), New Zealand (1),
Norway (19), Papua New Guinea (2), Portugal (21), Romania (22),
Russia (15), South Africa (22), Sweden (45), Taiwan (37), the Gambia
(1), United Kingdom (22), USA (138, including 83 in the mainland and
55 in Hawaii), Venezuela (1). Geographical origin is unknown for three
isolates. SDSE, Streptococcus dysgalactiae subspecies equisimilus. The
eight emm-types recovered prior to 1987 are as follows: emm-types
17, 34, 37, 38, 46, 47, 51 and 72.
TABLE 1. emm pattern groupings for 184 emm-types
emm pattern emm-types
Number of emm-types
for set of 184 (%)
A–C
1, 1–2, 1–4, 3, 5, 6, 12, 14, 17*, 18, 19, 23, 24, 26, 29, 30, 37*, 38/40*, 39, 46*, 47*, 51*, 54, 55, 57, st1RP31, st412,
st465, st818, st854, st3765, st4119, st7323, st980584 (stHK), stCK401, stil62, stmd216, stn165, stNS90
39 (21)
D
32, 33, 34*, 36, 41, 42, 43, 52, 53, 54, 56, 59, 64, 65/69, 67, 70, 71, 72*, 74, 80, 81, 83, 85, 86, 91, 93, 95, 97, 98, 99,
100, 101, 105, 108, 111, 115, 116, 119, 120, 121, 122, 123, st38, st62, st204, st221, st369, st809, st854, st1967,
st2037, st2105, st2461, st2861UK, st2911, st2917, st2926, st2940, st3757, st3850, st5282, st6030, st7395, st7700,
stCK249, stD432, stD631, stD633, stNS1033, stxh1
70 (38)
E
2, 4, 8, 9, 11, 13, 15, 22, 25, 27, 28, 44/61, 48, 49, 50/62, 58, 60, 63, 66, 68, 73, 75, 76, 77, 78, 79, 82, 84, 87, 88, 89,
90, 92, 94, 96, 102, 103, 104, 106, 107, 109, 110, 112, 113, 114, 117, 118, 124, st106M, st212, st213, st804, st833,
st1207, st1389, st1731, st2147, st2460, st2463, st2904, st6735, st7406, st11014, stknb1, stMTH81, stNS292,
stNS554, sts104
68 (37)
REA
st211, st1815
2 (1)
ND
31, st22, st1692, st1969, st9505, stil103, stpa57
7 (4)
Several identical emm-types were originally assigned two numbers: emm-type 44 is identical to emm-type 61 (emm-type 44/61), emm-types 50 and 62 (50/62), emm-types 65 and 69
(65/69), emm-types 38 and 40 (38/40). 223 emm-types are listed in the CDC database (18 September 2012) [21]. REA, rearranged emm pattern (atypical ampliﬁcation patterns).
ND, not determined.
*emm-types from strains isolated prior to 1987. emm-types not included in this study, but whose emm pattern grouping was previously established [31], are indicated in italics.
Isolates of emm-types 54 and st854 (underlined) are associated with more than one emm pattern group. Note that emm-types 7, 10, 16, 20, 21, 35 and 45 do not exist.
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proteins of pattern A–C were the longest (average 443
residues; 95% CI, 427–463), followed by pattern D (average
360 residues; 95% CI, 353–368), while those of pattern E were
the shortest (average 316 residues; 95% CI, 312–320)
(Student’s t-test; for two-way comparisons among all pattern
groups, t <0.001).
emm sequence data, including detailed annotation of
sequence repeats, for one representative of each of 175
emm-types are available in GenBank (accession numbers
JX028599-JX028772, JX472406). The ‘A’ repeats are deﬁned
as amino acid sequence repeats beginning within the ﬁrst 50
amino-terminal residues of the mature protein (i.e. emm typing
region). Similarly, ‘B’ repeats are deﬁned as sequence repeats
starting between residue 51 and the beginning of the CRR. The
‘C’ repeats are deﬁned by their homology with a highly
conserved 35-residue block (Data S2). Data show that a
majority (65%) of M proteins do not possess ‘A’ repeat
sequences. However, ‘A’ repeats are more frequent amongst
the pattern A–C group, where ~50% of M proteins have ‘A’
repeats, than amongst the D and E groups (33 and 30%
respectively). The presence of ‘B’ repeats also correlates with
the emm pattern groupings: 57, 51 and 15% of M proteins of
patterns A–C, D and E, respectively, possess ‘B’ repeats. When
present, 85% of the ‘B’ repeats consist of only two repeat units
in tandem (size range, 7–62 residues); higher numbers of ‘B’
repeat units were almost exclusively associated with M
proteins of the A–C group. Both ‘A’ and ‘B’ repeat sequences
originating from different emm-types were rarely found to
share extensive sequence homology. On the contrary, all M
proteins possess a CRR. The number of ‘C’ repeat units ranges
from one to ﬁve, with the vast majority of M-types (90%)
harboring three repeat units.
Based on the data obtained in this study, and on information
from published literature [4,9,10,13], we propose a new
structural model with three representative M proteins (Fig. 2).
M5, M80 and M77 proteins were selected as prototypes for
the structural characteristics within each emm pattern group.
This model provides the advantage of being far more
representative of M proteins from organisms recovered
worldwide.
Sequence conservation within an emm-type
In order to examine sequence heterogeneity from isolates of
the same emm-type originating from different geographical
regions, we identiﬁed all emm-types recovered from at least
ﬁve locations. Eighty emm-types encompassing 900 isolates
fulﬁlled this criterion (Table S3). Sixty-ﬁve (81%) emm-types
showed intra-emm-type differences in the size of M-proteins
(Table S3). Within each emm-type, an average mean of 69% of
isolates belonged to the most common size variant. The most
prevalent size variant was used as the basis for comparison
with other size variants within each emm-type. Comparisons of
the 900 protein sequences revealed 408 insertions or
deletions. Indels (i.e. insertions or deletions) were found at
similar frequencies across all emm pattern groups (data not
shown). As classically observed with coiled-coil proteins, 304
(75%) indels involved a sequence stretch that is a multiple of
seven residues, and this heptad periodicity increases from the
amino- to carboxy-terminal ends of the protein (Fig. 3). These
observations suggest that strong selective pressures preserve
the coiled-coil structure at the carboxy-terminal end of M
protein, whereas the amino-terminal extremity may better
tolerate variation in its higher order structure.
M proteins assigned to the same emm-type are highly
conserved across their surface-exposed portions, despite
differences in both geographical origins and clinical manifesta-
tions (Tables S1 and S3). After excluding gaps, M protein
sequences of the same emm-type are nearly identical, with an
average pairwise identity ranging from 88 to 100% (Data S3).
The median pairwise identity is 99%. Only two M-types,
emm14 (pattern A–C) and emm100 (pattern D), exhibit an
average pairwise identity <90%. One or two isolates belonging
to each of those two emm-types presented an atypical M
protein sequence, which was vastly different from the others
(protein identity between atypical and typical variants ranging
from 63 to 77%). Although many emm-types share highly
homologous central regions spanning residue 51 to the CRR, it
was extremely rare to ﬁnd a given emm-type paired with
multiple, highly divergent sub-N-terminal domains. Thus the
emm-type of an M protein is largely predictive of the structure
of the full-length protein, indicating that the emm-typing
method is far more informative than previously appreciated.
M protein conserved vaccine epitopes
The highly conserved nature of the CRR signiﬁes that CRR-
based vaccines can potentially target a wide range of M
proteins [16,24]. One such vaccine candidate, J14, consists of
14 amino acid residues derived from CRR [17]. In this study,
42 J14 variants were identiﬁed, including 17 newly recognized
variants (Data S4). Seven J14 variants accounted for 89% of all
J14 variants recovered from the 1078 isolates (Data S5). To
prevent bias due to over-representation of particular emm-
types, we also examined the distribution of J14 variants in
single representatives of each emm-type with similar results.
Speciﬁc J14 variants clearly segregate with emm pattern. For
example, M proteins belonging to pattern A–C almost
exclusively contain variant J14.0 in their third C-repeat unit,
pattern D proteins contain a mix of both variant J14.0 and
J14.1, whereas J14.0 is absent from pattern E proteins (data
not shown).
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Discussion
This study is the most comprehensive analysis of globally
distributed GAS M proteins undertaken. The data provide a
signiﬁcant increase in our understanding of the M protein
structure as a whole, a new understanding of the biological
relevance provided by older typing tools such as emm typing
and emm pattern determination and insights into the develop-
ment of future GAS vaccine formulations.
Approximately 75% of emm-types belong to the pattern D
and E groups. emm-types of patterns D and E are also
frequently recovered in epidemiological settings where there is
a high GAS-associated mortality burden and a very high
diversity of circulating emm-types [9,10,12,14,25]. Despite
their epidemiological relevance, these emm-types have not
been as extensively characterized as those of the pattern A–C
group. The structure of M6 protein served well in the past as
representative of M proteins. However, with increased
knowledge of the structure of additional M proteins, it has
become evident that extrapolations based on M6 protein are
limited. First, M6 is a pattern A–C emm-type, which collec-
tively accounts for only ~20% of emm-types. Secondly, M6
protein has ﬁve ‘A’ and ﬁve ‘B’ repeats and is non-represen-
tative of even the pattern A–C group because half of pattern
A–C emm-types lack ‘A’ repeats altogether and most possess
fewer ‘B’ repeat units. Third, the size of M6 protein is smaller
than most of the A–C pattern emm-type. Our data also
demonstrate that ‘A’ repeats are rarely found in the pattern D
and E emm-types while ‘B’ repeats are sometimes present, but
usually as a single tandem repeat.
The emm-typing region, despite its short length, is largely
predictive of the whole M protein sequence independent of
clinical association or geographical origin. This ﬁnding suggests
that emm-typing can be used to infer not only the N-terminal
portion of the protein, but the entire surface-exposed portion
as well. M proteins are multifunctional, having roles in
preventing phagocytosis, mediating adherence to host cells
and intracellular invasion, often through binding to human host
products such as ﬁbrinogen, factor H, albumin, IgA and IgG,
plasminogen and others [26]. Many host proteins are bound to
distinct regions or domains within M proteins. Therefore, the
emm-typing system may be predictive of a unique array of
biological functions for each emm-type.
In fungi, size variation generated by intragenic tandem
repeats within surface protein genes allows for rapid adaptation
to the environment and/or evasion of the host immune system
[27]. In GAS, as previously described for M6 organisms [28],
size differences in M protein from different isolates is also a
common feature, largely a result of differences in the number of
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FIG. 2. Three representative M proteins model. Three representative M proteins (M5, M80 and M77) were selected as prototypes for the
structural characteristics within each emm pattern group. M protein length and the size of the repeat and non-repeat regions are drawn to scale.
Pattern A–C emm-types represent the longest M proteins, with a (hyper)variable portion of about 230 residues. In comparison, pattern D and E
proteins possess a (hyper)variable portion of ~ 150 and 100 residues, respectively. The ‘A’ repeats are absent from the vast majority of M proteins
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sequence repeat units. The M6 protein size mutants display
heterogeneity in their antigenic and opsonogenic epitopes [28].
Our data show that intra-emm-type size variation occurs for
most emm-types, and it is evenly distributed across the three
emm pattern groups (data not shown). The signiﬁcant differ-
ences in M protein length observed between the three emm
pattern groups, and the close uniformity of M protein length
within each emm pattern group, have not been previously
described. Combined with knowledge that the emm pattern
groups are associated with different clinical manifestations [13],
it is tempting to speculate that M protein length underlies
distinct functional attributes, perhaps related to a capacity to
bind different subsets of host proteins. Future studies can
assess whether M protein size is an attribute that has an impact
on the virulence potential and clinical manifestations of GAS.
Our study is relevant to M protein-based vaccine design. A
new multivalent antigen containing amino-terminal fragments
from 30 M proteins showed unexpected in vitro cross-protec-
tion against isolates expressing M proteins not included in the
immunizing antigen [15]. Extensive cross-protection was not
demonstrated with a 26-valent antigen produced previously by
the same laboratory. The primary difference in the composition
of the two vaccines is a signiﬁcant increase in the number (from
11 to 18) of sequences representing M proteins belonging to
pattern E, in the 30-valent vaccine. Antibodies elicited by the
30-valent vaccine were tested against isolates belonging to 40
emm-types. Rates of cross-protection, measured by an opso-
nophagocytosis assay, differed by pattern group (pattern A–C,
60%; pattern D, 45%; pattern E, 84%) [15]. The underlying
mechanism for cross-protection against non-vaccine types is
not yet understood. However, these data suggest that the
emm-types belonging to the different pattern groups might
differ in their ability to induce cross-protective antibodies.
Another vaccine approach utilizes protective epitopes within
the highly conserved CRR, and aims to confer broad protection
against all GAS strains [19,24]. This and other studies have
shown that there are many variants of J14 sequences [17,29].
Our current study conﬁrms that virtually all C3 repeat units
harbour J14.0 or J14.1 variants and that a small number of J14
variants are predominant within a global collection of isolates.
M protein size and structure are characteristic of the emm
pattern group to which they belong. The pattern classiﬁcation,
based on the content of emm gene forms and their chromo-
somal arrangement, was also recognized as a strong marker of
preferred tissue sites of infection by GAS [13,29,30]. From this
exhaustive study, we propose that three M proteins, M5, M80
and M77, belonging to the three emm pattern groups A–C, D
and E, respectively, best represent the structures and possible
host-pathogen interactions mediated by M proteins. This new
model is likely to be a valuable tool for epidemiological,
molecular and vaccine studies.
Footnote
This study was presented in part at the 29th annual meeting of
the European Society for Pediatric Infectious Diseases in The
Hague, the Netherlands, 7–11 June 2011, at the 7th World
Congress of the World Society for Pediatric Infectious
Diseases in Melbourne, Australia, 16–19 November 2011, at
the Australian Society for Microbiology 2012 Annual Scientiﬁc
Meeting in Brisbane, Australia, 1–4 July 2012, and at 52th
ICAAC meeting in San Francisco, USA, 9–12 September 2012.
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